These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 34512861)
21. Identification of Resolvin D1 and Protectin D1 as Potential Therapeutic Agents for Treating Kidney Stones. Wang B; Wei J; Huangfu Q; Gao F; Qin L; Zhong J; Wen J; Ye Z; Yang X; Liu H Oxid Med Cell Longev; 2022; 2022():4345037. PubMed ID: 35251472 [TBL] [Abstract][Full Text] [Related]
22. Polydatin protects against calcium oxalate crystal-induced renal injury through the cytoplasmic/mitochondrial reactive oxygen species-NLRP3 inflammasome pathway. Liu J; Huang J; Gong B; Cheng S; Liu Y; Chen Y; Feng Q; Li J; Qiu M; Yu G; Liao Y Biomed Pharmacother; 2023 Nov; 167():115621. PubMed ID: 37793278 [TBL] [Abstract][Full Text] [Related]
23. Knockdown of lncRNA XIST inhibited apoptosis and inflammation in renal fibrosis via microRNA-19b-mediated downregulation of SOX6. Xia WP; Chen X; Ru F; He Y; Liu PH; Gan Y; Zhang B; Li Y; Dai GY; Jiang ZX; Chen Z Mol Immunol; 2021 Nov; 139():87-96. PubMed ID: 34461493 [TBL] [Abstract][Full Text] [Related]
24. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo. Shi J; Tan S; Song L; Song L; Wang Y Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117 [TBL] [Abstract][Full Text] [Related]
25. NLRP3 inflammasome mediates chronic intermittent hypoxia-induced renal injury implication of the microRNA-155/FOXO3a signaling pathway. Wu X; Chang SC; Jin J; Gu W; Li S J Cell Physiol; 2018 Dec; 233(12):9404-9415. PubMed ID: 29953588 [TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA X-inactive specific transcript regulates NLR family pyrin domain containing 3/caspase-1-mediated pyroptosis in diabetic nephropathy. Xu J; Wang Q; Song YF; Xu XH; Zhu H; Chen PD; Ren YP World J Diabetes; 2022 Apr; 13(4):358-375. PubMed ID: 35582664 [TBL] [Abstract][Full Text] [Related]
27. LncRNA-ATB participates in the regulation of calcium oxalate crystal-induced renal injury by sponging the miR-200 family. Li Y; Ding T; Hu H; Zhao T; Zhu C; Ding J; Yuan J; Guo Z Mol Med; 2021 Nov; 27(1):143. PubMed ID: 34736391 [TBL] [Abstract][Full Text] [Related]
28. LncRNA XIST mediates bovine mammary epithelial cell inflammatory response via NF-κB/NLRP3 inflammasome pathway. Ma M; Pei Y; Wang X; Feng J; Zhang Y; Gao MQ Cell Prolif; 2019 Jan; 52(1):e12525. PubMed ID: 30362186 [TBL] [Abstract][Full Text] [Related]
29. Sirtuin1 inhibits calcium oxalate crystal-induced kidney injury by regulating TLR4 signaling and macrophage-mediated inflammatory activation. Duan C; Liu H; Yang X; Liu J; Deng Y; Wang T; Xing J; Hu Z; Xu H Cell Signal; 2023 Dec; 112():110887. PubMed ID: 37717713 [TBL] [Abstract][Full Text] [Related]
30. CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart. Bian Y; Pang P; Li X; Yu S; Wang X; Liu K; Ju J; Wu H; Gao Y; Liu Q; Jia Y; Qu Z; Bi X; Mei Z; Yin X; Wang N; Du W; Yang B J Mol Cell Cardiol; 2021 Sep; 158():128-139. PubMed ID: 34043986 [TBL] [Abstract][Full Text] [Related]
31. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma. Zhao CH; Bai XF; Hu XH Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2505-2517. PubMed ID: 32196601 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression. Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185 [TBL] [Abstract][Full Text] [Related]
33. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury. Anders HJ; Suarez-Alvarez B; Grigorescu M; Foresto-Neto O; Steiger S; Desai J; Marschner JA; Honarpisheh M; Shi C; Jordan J; Müller L; Burzlaff N; Bäuerle T; Mulay SR Kidney Int; 2018 Mar; 93(3):656-669. PubMed ID: 29241624 [TBL] [Abstract][Full Text] [Related]
34. SP1-induced ZFAS1 aggravates sepsis-induced cardiac dysfunction via miR-590-3p/NLRP3-mediated autophagy and pyroptosis. Liu JJ; Li Y; Yang MS; Chen R; Cen CQ Arch Biochem Biophys; 2020 Nov; 695():108611. PubMed ID: 33002446 [TBL] [Abstract][Full Text] [Related]
35. LncRNA MALAT1 promoted high glucose-induced pyroptosis of renal tubular epithelial cell by sponging miR-30c targeting for NLRP3. Liu C; Zhuo H; Ye MY; Huang GX; Fan M; Huang XZ Kaohsiung J Med Sci; 2020 Sep; 36(9):682-691. PubMed ID: 32391974 [TBL] [Abstract][Full Text] [Related]
36. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3. Liao H; Zhang S; Qiao J Aging (Albany NY); 2020 Aug; 12(20):20198-20211. PubMed ID: 32852284 [TBL] [Abstract][Full Text] [Related]
37. miR-103a-3p Silencing Ameliorates Calcium Oxalate Deposition in Rat Kidney by Activating the UMOD/TRPV5 Axis. Cui Z; Li Y; Liu G; Jiang Y Dis Markers; 2022; 2022():2602717. PubMed ID: 35251369 [TBL] [Abstract][Full Text] [Related]
38. Hydroxycitric Acid Inhibits Renal Calcium Oxalate Deposition by Reducing Oxidative Stress and Inflammation. Liu X; Yuan P; Sun X; Chen Z Curr Mol Med; 2020; 20(7):527-535. PubMed ID: 31902360 [TBL] [Abstract][Full Text] [Related]
39. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A. Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928 [TBL] [Abstract][Full Text] [Related]
40. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p. Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]